Načítá se...
Heterogeneous multimodal biomarkers analysis for Alzheimer’s disease via Bayesian network
By 2050, it is estimated that the number of worldwide Alzheimer’s disease (AD) patients will quadruple from the current number of 36 million, while no proven disease-modifying treatments are available. At present, the underlying disease mechanisms remain under investigation, and recent studies sugge...
Uloženo v:
| Vydáno v: | EURASIP J Bioinform Syst Biol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4992017/ https://ncbi.nlm.nih.gov/pubmed/27610127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13637-016-0046-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|